DeepMed Research

The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

IM Ketamine vs Midazolam for Suicidal ER Patients

Phase 4

Suspended

Conditions: Depression, Unipolar
Depression, Bipolar
Suicidal Ideation

Interventions: Drug: Ketamine hydrochloride injection
Drug: Midazolam injection

First Posted Date: 2020-11-23

Last Posted Date: 2025-05-14

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 90

Registration Number: NCT04640636

Locations: 🇺🇸
Comprehensive Psychiatric Emergency Department of Columbia University Medical Center, New York, New York, United States

A Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses

Not Applicable

Completed

Conditions: Mental Disorders, Severe
Depressive Disorder
Bipolar Disorder
Schizophrenia and Related Disorders

Interventions: Behavioral: Opening Doors to Recovery
Behavioral: Case Management
Behavioral: Intensive Case Management

First Posted Date: 2020-11-03

Last Posted Date: 2024-10-18

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 240

Registration Number: NCT04612777

Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans

Phase 2

Suspended

Conditions: Pain
Hyperalgesia
Cannabis
Tolerance

Interventions: Drug: Cannabis

First Posted Date: 2020-10-22

Last Posted Date: 2024-12-04

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 16

Registration Number: NCT04596644

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)

Phase 1

Suspended

Conditions: Healthy

Interventions: Drug: Ketamine Hydrochloride

First Posted Date: 2020-10-19

Last Posted Date: 2024-07-03

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 35

Registration Number: NCT04589208

Locations: 🇺🇸
New York State Psychiatric, New York, New York, United States

Repeated Cannabis Administration on Experimental Pain and Abuse Liability

Phase 2

Suspended

Conditions: Cannabis
Pain
Hyperalgesia
Tolerance

Interventions: Drug: Cannabis

First Posted Date: 2020-10-06

Last Posted Date: 2025-02-19

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 16

Registration Number: NCT04576507

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)

Phase 4

Terminated

Conditions: Cognitive Impairment
Depression
Gait Impairment

Interventions: Drug: Carbidopa/levodopa
Drug: Placebo

First Posted Date: 2020-07-30

Last Posted Date: 2023-05-22

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 5

Registration Number: NCT04493320

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Clinical Trials of Multivalent Opioid Vaccine Components

Phase 1

Recruiting

Conditions: Opioid-use Disorder

Interventions: Biological: Oxy(Gly)4-sKLH vaccine - Low Dose
Biological: Placebo Oxy(Gly)4-sKLH vaccine
Biological: Oxy(Gly)4-sKLH vaccine - High Dose

First Posted Date: 2020-07-07

Last Posted Date: 2025-05-13

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 45

Registration Number: NCT04458545

Locations: 🇺🇸
Clinilabs Drug Development Corporation, Eatontown, New Jersey, United States
🇺🇸
New York State Psychiatric Institute: Division on Substance Use Disorders, New York, New York, United States

Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South Africa

Not Applicable

Completed

Conditions: Therapeutic Adherence and Compliance

Interventions: Behavioral: Feedback on DBS Concentrations

First Posted Date: 2020-04-03

Last Posted Date: 2023-01-20

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 60

Registration Number: NCT04333498

Locations: 🇺🇸
1051 Riverside Drive, New York, New York, United States
🇿🇦
Gugulethu Clinic, Cape Town, Western Cape, South Africa

Mechanisms of Emotion Regulation Underlying Successful CBT in Depression

Completed

Conditions: Major Depressive Disorder

Interventions: Behavioral: Cognitive Behavior Therapy (CBT)
Behavioral: Nonspecific Supportive Therapy (PBO)

First Posted Date: 2020-03-31

Last Posted Date: 2024-05-16

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 41

Registration Number: NCT04328103

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Pregabalin Trial for the Treatment of Alcohol Use Disorder

Phase 2

Suspended

Conditions: Alcohol Use Disorder

Interventions: Other: Placebo
Drug: Pregabalin

First Posted Date: 2020-03-26

Last Posted Date: 2025-02-14

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 50

Registration Number: NCT04322305

Locations: 🇺🇸
Nyspi-Stars, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy